The invention relates to a high-efficiency monatomic silver
nanowire antibiotic material which is characterized in that the monatomic silver
nanowire of the antibiotic material extends from the orifice of a framework-doped
manganese dioxide
molecular sieve into a hole. The
manganese dioxide
molecular sieve is characterized by being of a hollandite type
crystal structure; and the hole contains the monatomic silver
nanowire or / and A ions (A=K<+>, Na<+> or H<+>). The chemical general formula can be expressed as Agm(A)n[MxMn8-x]O16 (M=Mn<2+> / <3+>, Zn<2+> and Ti<4+>; A=K<+>, Na<+> or H<+>; m<=3; n<=2; and x<=2), [MxMn8-x]O16 represents the framework composition of the
manganese dioxide
molecular sieve, and Agm(A)n represents the hole composition of the manganese dioxide molecular
sieve. By mainly using the sterilization mechanism of catalytic
activated oxygen, silver of the monatomic silver nanowire antibiotic material is not consumed in the
sterilization process. Based on the synergetic effect of the quantized monatomic silver nanowire and the hollandite type manganese dioxide molecular
sieve, the antibiotic material has extremely
high oxygen activation performance, thereby leading to long-acting, high-efficiency and stable broad-spectrum antibiotic capability and having no adverse
side effect on a
human body. Thus, the antibiotic material can be widely used for preparing various
antibiotic products such as paint, plastic, rubber,
textile and the like.